Wiweka Kaszubska is the executive vice president, head of product development at Medicines for Malaria Venture. She is responsible for the late-stage development portfolio of anti-malarial drugs. Prior to joining MMV in 2012 and pursuing her interest in global health, she spent over 15 years in the pharmaceutical industry working across all phases of drug development. She obtained a Ph.D. in Biochemistry from the University of Illinois, and a bachelor's degree in Chemistry from the University of Chicago.